SCRS Talks

Society for Clinical Research Sites
  • 0,0 (0)
  • ZNANOSTI O ŽIVOTU
  • DVAPUT TJEDNO

SCRS Talks, hosted by the Society for Clinical Research Sites (SCRS), is a platform for clinical research industry professionals to hear about valuable information shaping the research industry today. These short interviews will provide new perspectives and insights on pressing topics, current events, and the research community.

  1. Alleviating Site Payment Burden with Third-Party Services

    PRIJE 5 D

    Alleviating Site Payment Burden with Third-Party Services

    In this episode, Jimmy Bechtel sits down with KimberLee Heidmann, Executive Vice President of Quality and Regulatory at Scout, to discuss the financial and administrative challenges clinical research sites face when managing patient payments and reimbursements. They explore how cash flow gaps impact site operations, why sites are adding overhead fees to contracts, and the burden of unexpected participant costs. KimberLee shares practical insights on how service providers like Scout can remove these pressures by handling logistics and payment services directly, allowing sites to focus their time and resources on what they do best: conducting trials and caring for patients. This conversation offers a fresh perspective on streamlining site operations and improving the trial ecosystem for everyone involved.

    22 min
  2. Net Zero and Beyond: Building a Culture of Sustainability at Clinical Research Sites

    13. TRA

    Net Zero and Beyond: Building a Culture of Sustainability at Clinical Research Sites

    Sustainability in clinical research does not have to be overwhelming. In this episode of SCRS Talks, Lauren Stockwell is joined by Paula Underhill of PPD part of Thermo Fisher Scientific and Clare Grace, CEO of EMS Healthcare and the 2025 Excellence in Site Sustainability Award recipient. Claire walks through the concrete changes EMS implemented across its mobile unit model, including solar integration, employee-led sustainability committees, and science-based targets aligned with the Paris Agreement. Paula adds context on what the judging panel found compelling and how CROs can serve as true sustainability partners rather than just cheerleaders. Whether your site is just getting started or well on its way, this conversation will leave you with a clear message: start small, start now.

    15 min
  3. What Sites Need to Know Before Taking On CNS Trials

    6. TRA

    What Sites Need to Know Before Taking On CNS Trials

    Jimmy Bechtel sits down with Jeff Zucker, Chief Development Officer, and Brandon Lenfest, Regional Director at Tekton Research, to dig into what makes CNS and neuroscience trials uniquely challenging for sites. They cover why patient identification in this space requires a completely different approach, the often overlooked but critical role caregivers play, and what sites can do to keep patients engaged through the full length of a study. Jeff and Brandon also get into the balancing act of providing empathetic care while managing placebo response, and share practical advice for sites considering making the move into CNS research for the first time.

    24 min
  4. Guide to Streamlining Study Startup

    30. OŽU

    Guide to Streamlining Study Startup

    Dana Kudrnova from Novotech shares proven strategies to accelerate study startup by overcoming regulatory and administrative bottlenecks. Learn how data-driven KPIs, mandatory templates, and unified technology transform unpredictable timelines into streamlined milestones. Dana emphasizes that while AI provides speed, active ownership and human oversight are what truly prevent document delays. This episode highlights why proactive communication between CRAs and sites is the secret to surfacing issues early and moving from site selection to first patient dosed more efficiently.

    14 min
  5. De-Risking Clinical Trials with Flexible Site Models

    23. OŽU

    De-Risking Clinical Trials with Flexible Site Models

    Jimmy Bechtel talks with Darcy Forman, COO of Lightship, about how hybrid site models can reduce operational risk in clinical trials. They discuss matching visit types to the right setting (clinic, home, or mobile), lessons learned from the pandemic's rapid shift to decentralized trials, and how to maintain strong investigator oversight across different delivery models. Darcy shares practical insights on what it takes to implement flexible approaches successfully, including the importance of investigator buy-in, standardized processes, and building trust-based relationships between sites, sponsors, and CROs.

    21 min
  6. Growing with Purpose: Balancing Site Identity and Network Scale

    16. OŽU

    Growing with Purpose: Balancing Site Identity and Network Scale

    Lauren Chazal, Chief Business Development Officer at Headlands Research, shares insights on growing from individual research sites to a 23-center network while preserving local culture and patient focus. Learn how Headlands maintains site identity during expansion, implements strategies for reaching diverse patient populations, and addresses the business realities sponsors often overlook. Lauren offers practical advice for site leaders on sustainable growth, selecting the right network partner, and maintaining a patient-centered mission at the core of operations as the industry continues to evolve and consolidate.

    19 min
  7. The Measurable Value of Patient Voice in Trials

    10. OŽU

    The Measurable Value of Patient Voice in Trials

    What makes patient voice sessions the most impactful part of every SCRS summit? Jade Tuttle from Syneos Health breaks down what she learned from featuring patients at four summits in 2025. The recurring theme? There are still massive gaps in our systems, but sites that adapt proactively and deliver emotionally intelligent trials create transformative patient experiences. Jade shares standout stories, explains why regulatory bodies are increasingly mandating patient-centric practices, and reveals the measurable business case for patient-informed trials. She challenges the industry to move beyond reactive approaches and partner with patient advocacy organizations early in trial design. Learn how to turn "patient-centricity" from a buzzword into real, tangible practice.

    16 min
  8. Breaking Down Geographic Barriers in Clinical Research

    9. OŽU

    Breaking Down Geographic Barriers in Clinical Research

    What if patients could participate in clinical trials from their living room instead of driving hours to a site? Tyler Van Horn, CEO of Science 37, explains how their direct-to-patient site model works. With one site covering all 50 states, Science 37 sends research-grade nurses to patients' homes, ships investigational products directly to participants, and uses telemedicine for investigator oversight. Tyler breaks down how they maintain quality (they've passed three FDA inspections with no findings), manage the logistics of home visits, educate sponsors on this approach, and create a high-touch patient experience that leads to better retention rates. If you've been curious about how decentralized trials actually work in practice or how to reach patients in research deserts, this conversation is for you.

    23 min
Pogledajte sve (202)

Opis

SCRS Talks, hosted by the Society for Clinical Research Sites (SCRS), is a platform for clinical research industry professionals to hear about valuable information shaping the research industry today. These short interviews will provide new perspectives and insights on pressing topics, current events, and the research community.

Informacije

  • Autor
    Society for Clinical Research Sites
  • Aktivne godine
    2020. - 2026.
  • Epizode
    202
  • Ocjena
    Korektno
  • Copyright
    © 2026 SCRS Talks
  • Web‑stranica emisije
    SCRS Talks

Također bi vam se moglo svidjeti